Cathay Biotech Inc. (SHA:688065)
China flag China · Delayed Price · Currency is CNY
39.03
-0.18 (-0.46%)
Nov 6, 2026, 3:00 PM CST

Cathay Biotech Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Cathay Biotech stock has a consensus rating of "Strong Buy" and an average price target of ¥55.09. The average 1-year stock price forecast is 41.15% higher than the current stock price, while the lowest is ¥50.00 (+28.11%) and the highest is ¥60.18 (+54.19%).

Price Target: ¥55.09 (+41.15%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price¥50.00¥55.09¥55.09¥60.18
Change+28.11%+41.15%+41.15%+54.19%

Analyst Ratings

The average analyst rating for Cathay Biotech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Aug '26Oct '26
Strong Buy211112
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total211112

Financial Forecast

Revenue This Year
3.71B
from 3.30B
Increased by 12.62%
Revenue Next Year
4.29B
from 3.71B
Increased by 15.49%
EPS This Year
n/a
EPS Next Year
n/a
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
2.36B2.44B2.11B2.96B3.30B3.71B
Revenue Growth
57.86%3.28%-13.39%39.91%11.40%12.62%
Gross Profit
837.21M829.20M579.23M836.44M991.20M1.38B
Gross Margin
35.42%33.97%27.40%28.28%30.08%37.27%
Operating Income
499.25M406.61M165.55M396.10M526.78M895.96M
Net Income
594.72M553.27M366.52M488.96M560.72M784.82M
Dividend / Share
0.320.180.190.400.450.42
Dividend Growth
-43.75%-44.00%5.56%110.53%12.50%-6.67%
No. Analysts
-----2
Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High3.9B
Avg3.7B
Low3.6B

Revenue Growth

Revenue Growth202620272028
High
17.0%
Avg
12.6%
Low
8.3%

EPS Forecast

EPS202620272028
High-
Avg-
Low-

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-